-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Immatics Presents Clinical Activity Of Ima402 Prame Bispecific And Ima203cd8 Prame Cell Therapy Across Advanced Solid Tumors In Two Oral Presentations

Reuters·10/24/2026 06:42:59

Please log in to view news